arginine has been researched along with deferoxamine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gugler, E; Hirt, A; Imbach, P; Molinari, B; Tönz, O; Zuppinger, K; Zurbrügg, RP | 1 |
| Park, J; Rikihisa, Y | 1 |
| Bienzle, U; Chaves, MF; Kremsner, PG; Neifer, S; Rudolph, R | 1 |
| Hansen, PR; Stawski, G | 1 |
| Doppler, W; Fuchs, D; Goossen, B; Grünewald, K; Hentze, MW; Pantopoulos, K; Wachter, H; Weiss, G; Werner-Felmayer, G | 1 |
| Macdonald, VW; Motterlini, R | 1 |
| Duckles, SP; Li, YJ | 1 |
| Carr, J; Esbensen, K; McAbee, DD; Nowatzke, W; Oehler, C; Opferman, JT; Sbaschnig, E; Sitaram, M | 1 |
| Pyzdrowski, KL; Redmon, JB; Robertson, RP | 1 |
| Austerheim, AM; Dalen, H; Davis, MG; Gulbrandsen, TF; Hagen, PO; Svendsen, E | 1 |
| Evans, TW; Griffiths, MJ; Gutteridge, JM; Messent, M; Quinlan, GJ | 1 |
| Attali, JR; Ledoux, S; Nitenberg, A; Valensi, P | 1 |
| Attali, JR; Ledoux, S; Nitenberg, A; Paycha, F; Sachs, R; Valensi, P | 1 |
| Carbonell, T; Mitjavila, MT; Ródenas, J | 1 |
| Kim, JE; Sheen, YY | 1 |
| Dunster, C; Grieve, DJ; Kelly, FJ; Li, JM; MacCarthy, PA; Shah, AM | 1 |
| Hooper, NM; Lee, HB; Park, HS; Park, SW; Yoon, HJ | 1 |
| Balogh, N; Gaál, T; Krausz, F; Lévai, P; Ribiczeyné, PS; Vajdovich, P | 1 |
| Aitken, RJ; Baker, MA; McLaughlin, EA; Ryan, AL | 1 |
| Gol, A; Kadkhodaee, M | 1 |
| Hatano, M; Igarashi, M; Kakeya, H; Kishimoto, S; Nishimura, S | 1 |
| Farinelli, SE; Greene, LA | 1 |
1 review(s) available for arginine and deferoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine and deferoxamine
| Article | Year |
|---|---|
[Response of the coronary arteries to cold test and flow velocity increase is improved by deferoxamine but not by L-arginine in diabetic patients].
Topics: Arginine; Blood Flow Velocity; Cold Temperature; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Deferoxamine; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Hemodynamics; Humans; Male; Middle Aged; Nitric Oxide; Vasoconstriction; Vasodilation; Vasodilator Agents | 1997 |
22 other study(ies) available for arginine and deferoxamine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.
Topics: Adolescent; Arginine; Blood Glucose; Child; Child, Preschool; Deferoxamine; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Growth Hormone; Hemochromatosis; Humans; Insulin; Iron; Male; Thalassemia; Transfusion Reaction | 1979 |
L-arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon.
Topics: Animals; Arginine; Cyclic GMP; Deferoxamine; Ehrlichia; Female; Interferon-gamma; Macrophages; Mice; Nitric Oxide; Nitrites; Nitroprusside; omega-N-Methylarginine | 1992 |
Interferon-gamma induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine.
Topics: Animals; Arginine; Chloroquine; Deferoxamine; Female; Immunization; Interferon-gamma; Liver; Malaria; Mice; Mice, Inbred BALB C; omega-N-Methylarginine; Pentoxifylline; Tumor Necrosis Factor-alpha | 1992 |
Neutrophil mediated damage to isolated myocytes after anoxia and reoxygenation.
Topics: alpha-Macroglobulins; Animals; Antibodies, Monoclonal; Antigens, CD; Arginine; Catalase; CD18 Antigens; Cells, Cultured; Deferoxamine; Histidine; Interleukin-1; L-Lactate Dehydrogenase; Myocardial Reperfusion Injury; Myocardium; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pentoxifylline; Proteins; Rats; Receptors, Leukocyte-Adhesion; Serpins; Superoxide Dismutase | 1994 |
Stimulation of IRE-BP activity of IRF by tetrahydrobiopterin and cytokine dependent induction of nitric oxide synthase.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Biopterins; Cell Line; Chloramphenicol O-Acetyltransferase; Deferoxamine; Humans; Interferon-gamma; Iron; Iron-Regulatory Proteins; Kinetics; Leukemia, Myeloid, Acute; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; RNA Probes; RNA-Binding Proteins; Transfection; Tumor Cells, Cultured | 1994 |
Vasoconstrictor effects in isolated rabbit heart perfused with bis(3,5-dibromosalicyl)fumarate cross-linked hemoglobin (alpha alpha Hb).
Topics: Acetylcholine; Animals; Arginine; Aspirin; Blood Pressure; Blood Substitutes; Deferoxamine; Drug Synergism; Heart; Hemoglobins; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Perfusion; Rabbits; Vasoconstriction | 1994 |
Mechanisms of relaxation by pyrogallol and methylthioninium chloride in perfused rat mesenteric artery.
Topics: Animals; Arginine; Capsaicin; Catalase; Deferoxamine; Dose-Response Relationship, Drug; Indomethacin; Male; Mesenteric Arteries; Methylene Blue; Muscle Relaxation; Nitroarginine; Pyrogallol; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vasodilation | 1994 |
Endocytosis and degradation of bovine apo- and holo-lactoferrin by isolated rat hepatocytes are mediated by recycling calcium-dependent binding sites.
Topics: Animals; Arginine; Binding Sites; Calcium; Cattle; Clathrin; Deferoxamine; Egtazic Acid; Endocytosis; Iodine Radioisotopes; Iron; Kinetics; Lactoferrin; Liver; Lysine; Male; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface | 1993 |
No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin.
Topics: Arginine; Blood Glucose; C-Peptide; Deferoxamine; Diabetes Mellitus, Type 2; Ferritins; Follow-Up Studies; Humans; Insulin; Insulin Secretion; Kinetics; Middle Aged; Reference Values; Time Factors | 1993 |
Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Carotid Artery, Common; Deferoxamine; Hyperplasia; Jugular Veins; Rabbits; Siderophores; Tunica Intima | 1996 |
Ischaemia--reperfusion injury in the rat is modulated by superoxide generation and leads to an augmentation of the hypoxic pulmonary vascular response.
Topics: Animals; Arginine; Catalase; Deferoxamine; Ischemia; Linolenic Acids; Lung; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidoreductases; Rats; Reactive Oxygen Species; Reperfusion Injury; Superoxide Dismutase; Vasoconstriction | 1996 |
Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.
Topics: Adult; Antidotes; Arginine; Cold Temperature; Coronary Angiography; Coronary Vessels; Deferoxamine; Diabetes Mellitus, Type 2; Female; Hemodynamics; Humans; Iron Chelating Agents; Male; Middle Aged; Papaverine; Risk Factors; Stress, Physiological; Vasodilator Agents; Vasomotor System | 1998 |
Different roles for nitrogen monoxide and peroxynitrite in lipid peroxidation induced by activated neutrophils.
Topics: Animals; Arginine; Carrageenan; Deferoxamine; Exudates and Transudates; Granuloma; Inflammation; Lipid Peroxidation; Male; Malondialdehyde; Neutrophils; Nitrates; Nitric Oxide; Ornithine; Oxidants; Pentetic Acid; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Superoxides | 2000 |
Nitric oxide inhibits dioxin action for the stimulation of Cyp1a1 promoter activity.
Topics: Animals; Arginine; Cells, Cultured; Cobalt; Cytochrome P-450 CYP1A1; Deferoxamine; Dioxins; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Reporter; Lipopolysaccharides; Luciferases; Mice; Nitric Oxide; Nitroarginine; Nitroprusside; Picolinic Acids; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Teratogens; Transfection | 2000 |
Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase.
Topics: Animals; Antioxidants; Arginine; Ascorbic Acid; Biopterins; Deferoxamine; Drug Synergism; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Guinea Pigs; Heart Ventricles; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Malondialdehyde; Metalloporphyrins; Myocardial Contraction; NADPH Oxidases; Oxidation-Reduction; Reactive Oxygen Species; Substance P | 2001 |
Nitric oxide inhibits the shedding of the glycosylphosphatidylinositol-anchored dipeptidase from porcine renal proximal tubules.
Topics: Animals; Arginine; Blotting, Western; Deferoxamine; Dithiothreitol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estrenes; Glycosylphosphatidylinositols; Kidney; Kidney Tubules; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitroprusside; Penicillamine; Phosphodiesterase Inhibitors; Protein Binding; Pyrrolidinones; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Superoxide Dismutase; Swine; Time Factors; Type C Phospholipases | 2002 |
Effect of deferoxamine and L-arginine treatment on lipid peroxidation in an intestinal ischaemia-reperfusion model in rats.
Topics: Animals; Arginine; Deferoxamine; Disease Models, Animal; Enzyme Inhibitors; Erythrocytes; Female; Glutathione Peroxidase; Ischemia; Jejunum; Lipid Peroxidation; Malondialdehyde; Nitric Oxide; Rats; Rats, Wistar; Reperfusion; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2002 |
Redox activity associated with the maturation and capacitation of mammalian spermatozoa.
Topics: 4-Chloromercuribenzenesulfonate; Acridines; Acrosome Reaction; Animals; Arginine; Bicarbonates; Calcium; Capsaicin; Catalase; Culture Media; Deferoxamine; Diterpenes; Enzyme Inhibitors; Epididymis; Fructose; Glucose; Indicators and Reagents; Iron Chelating Agents; Luminol; Male; Microscopy, Confocal; Microscopy, Fluorescence; Models, Biological; NADH, NADPH Oxidoreductases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Onium Compounds; Oxidation-Reduction; Peroxidase; Rats; Rats, Wistar; Reactive Oxygen Species; Rotenone; Spermatozoa; Superoxide Dismutase; Temperature; Time Factors; Uncoupling Agents | 2004 |
The role of nitric oxide in iron-induced rat renal injury.
Topics: Animals; Arginine; Deferoxamine; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Iron; Iron Chelating Agents; Iron Overload; Kidney; Kidney Diseases; Kidney Function Tests; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Sprague-Dawley; Vitamin E | 2004 |
Total Synthesis and Antimicrobial Activity of Chlorocatechelin A.
Topics: Animals; Anti-Bacterial Agents; Arginine; Deferoxamine; Dipeptides; Fishes; Molecular Structure; Pasteurella; Siderophores; Structure-Activity Relationship | 2015 |
Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support.
Topics: Animals; Aphidicolin; Apoptosis; Cell Cycle; Cell Division; Ciclopirox; Cyclic AMP; Deferoxamine; G1 Phase; Mimosine; Mitosis; Nerve Growth Factors; Neurons; Nocodazole; PC12 Cells; Pyridones; Rats; Superior Cervical Ganglion; Teniposide; Thionucleotides | 1996 |